Valiant Organics
- P/E
- 25.01
Key Fundamentals
MicrocapChemicals & PetrochemicalsChemicalsPrice-based figures as of · EPS basis: Consolidated · TTM
- ROCE
- 6.21%
- Debt to Equity
- 0.31
- EPS (TTM)
- ₹17.34
- Book Value
- ₹270.88
- Market Cap
- —
- P/E (TTM)
- 25.01
- P/B
- 1.60
- ROE
- 4.00%
- Dividend Yield
- 0.24%
- EBITDA
- ₹95.10 Cr
- 52W High
- ₹505.00
- 52W Low
- ₹195.00
- Day Range
- ₹406.05 – ₹445.00
- Volume
- 1,34,648
Peer Comparison
Commodities › Chemicals › Specialty Chemicals
| ₹1,510.20 | 58.04 | ₹1,54,107 Cr | 13.72 | 1.42% | 23.90% | 31.00% | ₹15,399 Cr | ₹2,677 Cr | |
| ₹4,613.30 | 83.76 | ₹49,073 Cr | 6.04 | 0.07% | 7.82% | 9.64% | ₹5,303 Cr | ₹600 Cr | |
| ₹8,785.00 | 57.03 | ₹44,060 Cr | 10.10 | 0.09% | 19.60% | 21.00% | ₹3,634 Cr | ₹789 Cr | |
| ₹1,578.40 | 27.48 | ₹20,919 Cr | 3.32 | 0.49% | 9.82% | 11.40% | ₹8,575 Cr | ₹784 Cr | |
| ₹1,540.70 | 86.90 | ₹20,030 Cr | 7.88 | 0.00% | 9.66% | 11.90% | ₹1,231 Cr | ₹235 Cr | |
| ₹447.55 | 30.57 | ₹15,838 Cr | 2.59 | 0.23% | 7.13% | 6.86% | ₹9,010 Cr | ₹531 Cr | |
| ₹5,156.50 | 19.67 | ₹14,827 Cr | 2.31 | 0.59% | 11.50% | 14.90% | ₹6,969 Cr | ₹788 Cr | |
| ₹433.70 | 25.01 | ₹1,163 Cr | 1.60 | 0.24% | 4.00% | 6.21% | ₹766 Cr | ₹49 Cr | |
| Median 8 companies | ₹1,559.55 | 43.80 | ₹20,474 Cr | 4.68 | 0.24% | 9.74% | 11.65% | ₹6,136 Cr | ₹692 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 100/100
Category scores
- Quality
- 59
- Good
- Returns, margins, earnings quality 22% weight
- Valuation
- 46
- Average
- Cheap vs sector & own history 24% weight
- Growth
- 29
- Poor
- Sales & profit trajectory 9% weight
- Financial Health
- 39
- Weak
- Solvency, leverage, coverage 9% weight
- Momentum
- 92
- Strong
- Trend strength, vol-adjusted 12% weight
- Ownership
- 72
- Strong
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
No strengths listed
Weaknesses
2- The company has delivered a poor sales growth of 5.16% over past five years.
- Company has a low return on equity of 0.69% over last 3 years.
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Bullish | 4 | 7 | 8 |
| Oscillators | Bearish | 2 | 7 | 0 |
| Moving Averages | Strong Bullish | 2 | 0 | 8 |
Oscillators
Bearish
Overall
Bullish
Moving Averages
Strong Bullish
Key readings
- RSI (14)
- 51.05
- Neutral
- MACD (12,26,9)
- 3.64
- Bearish
- SMA (50)
- 402.18
- Bullish
- SMA (200)
- 300.84
- Bullish
As of
Growth Rate
From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.
Revenue
| 10Y | +30.38% |
|---|---|
| 5Y | +5.15% |
| 3Y | −6.81% |
| 1Y | +2.64% |
| TTM | +1.46% |
Net profit
| 10Y | +13.02% |
|---|---|
| 5Y | −21.63% |
| 3Y | −23.52% |
| 1Y | Turned to profit |
| TTM | +716.67% |
Operating cash flow
| 10Y | +9.35% |
|---|---|
| 5Y | −17.48% |
| 3Y | −37.82% |
| 1Y | −25.42% |
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 10Y | −18.85 pp |
|---|---|
| 5Y | −15.43 pp |
| 3Y | −2.33 pp |
| 1Y | +4.41 pp |
| TTM | +5.37 pp |
Revenue by year
| Mar 2017 | ₹73.00 Cr |
|---|---|
| Mar 2018 | ₹121 Cr |
| Mar 2019 | ₹606 Cr |
| Mar 2020 | ₹584 Cr |
| Mar 2021 | ₹574 Cr |
| Mar 2022 | ₹948 Cr |
| Mar 2023 | ₹912 Cr |
| Mar 2024 | ₹677 Cr |
| Mar 2025 | ₹719 Cr |
| Mar 2026 | ₹738 Cr |
Net profit by year
| Mar 2017 | ₹12.00 Cr |
|---|---|
| Mar 2018 | ₹16.00 Cr |
| Mar 2019 | ₹121 Cr |
| Mar 2020 | ₹124 Cr |
| Mar 2021 | ₹115 Cr |
| Mar 2022 | ₹103 Cr |
| Mar 2023 | ₹76.00 Cr |
| Mar 2024 | −₹3.00 Cr |
| Mar 2025 | −₹3.00 Cr |
| Mar 2026 | ₹34.00 Cr |
Quarterly Results
₹ Cr| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 177 | 182 | 141 | 177 | 168 | 160 | 187 | 204 | 204 | 157 | 159 | 218 | 232 |
| Expenses | 156 | 165 | 138 | 179 | 152 | 158 | 172 | 183 | 180 | 136 | 143 | 191 | 190 |
| Operating Profit | 20 | 17 | 4 | −2 | 16 | 2 | 15 | 21 | 25 | 21 | 16 | 26 | 42 |
| OPM % | 11% | 9% | 2.7% | −1% | 9% | 1.5% | 8% | 10% | 12% | 13% | 10% | 12% | 18% |
| Other Income | 6 | 0 | 0 | 2 | 0 | 2 | 5 | 1 | 1 | 0 | 7 | 4 | 3 |
| Interest | 4 | 4 | 4 | 7 | 5 | 8 | 6 | 5 | 6 | 4 | 5 | 3 | 5 |
| Depreciation | 8 | 8 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 10 | 10 | 10 | 10 |
| PBT | 14 | 5 | −9 | −16 | 2 | −13 | 6 | 7 | 10 | 7 | 8 | 17 | 29 |
| Tax % | 25% | 26% | −22% | −32% | 118% | −12% | 16% | 44% | 28% | 24% | 27% | 11% | 25% |
| Net Profit | 10 | 4 | −7 | −11 | 0 | −11 | 5 | 4 | 8 | 6 | 6 | 15 | 22 |
| EPS (₹) | 3.82 | 1.44 | −2.43 | −3.86 | −0.16 | −4.04 | 1.68 | 1.41 | 2.71 | 2 | 2.16 | 5.4 | 7.78 |
Profit & Loss
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 59 | 52 | 73 | 121 | 606 | 584 | 574 | 948 | 912 | 677 | 719 | 738 | 766 |
| Expenses | 48 | 36 | 55 | 94 | 426 | 410 | 417 | 783 | 782 | 638 | 665 | 650 | 661 |
| Operating Profit | 11 | 16 | 18 | 26 | 179 | 174 | 157 | 165 | 130 | 40 | 54 | 88 | 105 |
| OPM % | 19% | 30% | 25% | 22% | 30% | 30% | 27% | 17% | 14% | 6% | 8% | 12% | 14% |
| Other Income | 1 | 1 | 2 | 1 | 5 | 5 | 17 | 6 | 8 | 9 | 8 | 13 | 14 |
| Interest | 1 | 0 | 0 | 0 | 2 | 1 | 3 | 6 | 11 | 19 | 24 | 18 | 17 |
| Depreciation | 1 | 1 | 2 | 2 | 12 | 13 | 19 | 27 | 28 | 34 | 36 | 40 | 40 |
| PBT | 11 | 16 | 18 | 25 | 171 | 165 | 152 | 137 | 100 | −5 | 2 | 43 | 62 |
| Tax % | 34% | 35% | 35% | 35% | 29% | 25% | 25% | 25% | 24% | −41% | 224% | 20% | — |
| Net Profit | 7 | 10 | 12 | 16 | 121 | 124 | 115 | 103 | 76 | −3 | −3 | 34 | 49 |
| EPS (₹) | 104 | 14.03 | 15.92 | 13.97 | 104 | 51 | 42.2 | 37.91 | 27.83 | −1.1 | −1.07 | 12.26 | 17.34 |
| Div. Payout % | 50% | 71% | 16% | 23% | 6% | 11% | 12% | 9% | 4% | 0% | 0% | 0% | — |
Balance Sheet
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.36 | 4 | 4 | 6 | 6 | 12 | 27 | 27 | 27 | 28 | 28 | 28 |
| Reserves | 21 | 19 | 42 | 53 | 254 | 374 | 475 | 576 | 638 | 637 | 634 | 669 |
| Borrowings | 8 | 1 | 1 | 1 | 53 | 119 | 150 | 306 | 220 | 216 | 212 | 219 |
| Other Liabilities | 11 | 17 | 23 | 36 | 89 | 125 | 154 | 174 | 220 | 262 | 206 | 216 |
| Total Liabilities | 40 | 41 | 69 | 96 | 402 | 629 | 806 | 1,083 | 1,106 | 1,142 | 1,079 | 1,132 |
| Fixed Assets | 11 | 12 | 26 | 31 | 130 | 256 | 478 | 509 | 610 | 630 | 644 | 683 |
| CWIP | 1 | 0 | 0 | 0 | 66 | 129 | 46 | 110 | 70 | 86 | 66 | 21 |
| Investments | 2 | 2 | 7 | 7 | 20 | 34 | 42 | 53 | 53 | 54 | 54 | 64 |
| Other Assets | 26 | 26 | 35 | 58 | 187 | 210 | 240 | 410 | 373 | 371 | 315 | 365 |
| Total Assets | 40 | 41 | 69 | 96 | 402 | 629 | 806 | 1,083 | 1,106 | 1,142 | 1,079 | 1,132 |
Cash Flow
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 6 | 18 | 9 | 18 | 77 | 160 | 115 | −11 | 183 | 85 | 59 | 44 |
| Investing | −1 | −1 | −1 | −6 | −88 | −191 | −135 | −120 | −91 | −65 | −27 | −39 |
| Financing | −5 | −16 | −4 | −5 | 2 | 35 | 22 | 146 | −109 | −23 | −28 | −11 |
| Net Cash Flow | 0 | 0 | 4 | 7 | −8 | 5 | 1 | 14 | −17 | −3 | 4 | −6 |
| Free Cash Flow | 5 | 16 | 5 | 11 | −6 | −42 | −37 | −126 | 96 | 20 | 29 | 11 |
| CFO/OP | 89 | 150 | 87 | 97 | 69 | 115 | 94 | 10 | 154 | 218 | 108 | 47 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 74 | 71 | 88 | 112 | 73 | 69 | 74 | 97 | 85 | 113 | 88 | 120 |
| Inventory Days | 42 | 36 | 97 | 44 | 45 | 47 | 85 | 58 | 69 | 104 | 71 | 77 |
| Days Payable | 7 | 50 | 130 | 154 | 80 | 97 | 135 | 76 | 100 | 189 | 117 | 102 |
| Cash Conversion Cycle | 110 | 57 | 55 | 2 | 37 | 20 | 25 | 80 | 54 | 28 | 43 | 96 |
| Working Capital Days | 53 | 59 | 69 | 41 | 51 | 21 | 4 | 9 | 4 | −7 | −16 | 19 |
| ROCE % | 43% | 61% | 52% | 48% | 91% | 41% | 27% | 18% | 12% | 1% | 3% | 6% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Valiant Organics insights
63 extracted metrics across FY15–FY27.
Documents
- 16 May 2026
- 5 Aug 2026
- 7 May 2025
- 4 Jun 2024
- 23 Feb 2024
- 20 Nov 2023
- General announcements 6 Oct 2026
- General announcements 1 Oct 2026
Frequently Asked Questions about Valiant Organics
What does Valiant Organics Ltd do?
Where is Valiant Organics Ltd (VALIANTORG) listed?
Which sector does Valiant Organics Ltd belong to?
What is the PE ratio of Valiant Organics Ltd?
What is the 52-week high and low of Valiant Organics Ltd?
Does Valiant Organics Ltd pay dividends?
What is the Return on Equity (ROE) of Valiant Organics Ltd?
Company Information
Incorporated in 1984, Valiant Organics Ltd manufactures and deals in specialty chemicals and pharma intermediates
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/VALIANTORG.md for Valiant Organics Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.